Candidate genes and sensory functions in health and irritable bowel syndrome.
Adrenergic and serotonergic (ADR-SER) mechanisms alter gut (GI) function; these effects are mediated through G protein transduction. Candidate genetic variations in ADR-SER were significantly associated with somatic scores in irritable bowel syndrome (IBS) and gastric emptying but not small bowel or colonic transit. Our aim was to assess whether candidate ADR-SER genes are associated with motor and sensory GI functions in IBS and subgroups on the basis of bowel dysfunction. In 122 patients with IBS and 39 healthy controls, we assessed gastrointestinal somatic symptoms and affect by validated questionnaires. We measured: gastric volume (GV), maximum tolerated volume, rectal compliance, sensation thresholds and ratings, and genetic variations including alpha2A (C-1291G), alpha2C (Del 332-325), GNbeta3 (C825T), and 5-HTTLPR. Demographics and genotype distributions were similar in the patients with IBS subgrouped on bowel function. There were significant associations between 5-HTTLPR SS genotype and absence of IBS symptoms and between 5-HTTLPR LS/SS genotype and increased rectal compliance and increased pain ratings, particularly at 12 and 24 mmHg distensions. GNbeta3 was associated only with fasting GV; we did not detect associations between alpha2A genotype and the gastrointestinal sensory or motor functions tested. We concluded that 5-HTTLPR LS/SS genotype is associated with both increased pain sensation and increased rectal compliance though the latter effect is unlikely to contribute to increased pain sensation ratings with LS/SS genotype. The data suggest the hypotheses that the endophenotype of visceral hypersensitivity in IBS may be partly related to genetic factors, and the association of GNbeta3 with fasting GV may explain, in part, the reported association of GNbeta3 with dyspepsia.
Clinical Enteric Neuroscience Translational and Epidemiological Research (C.E.N.T.E.R.), Mayo Clinic, Charlton 8-110, 200 1st St. SW, Rochester, MN 55905, USA. camilleri.michael@mayo.edu
Michael
M
Camilleri
Irene
I
Busciglio
Paula
P
Carlson
Sanna
S
McKinzie
Duane
D
Burton
Kari
K
Baxter
Michael
M
Ryks
Alan R
AR
Zinsmeister
D000328:Adult; D005260:Female; D005838:Genotype; D020962:Heterotrimeric GTP-Binding Proteins / Q000235:genetics; D006801:Humans; D043183:Irritable Bowel Syndrome / Q000235:genetics* / Q000503:physiopathology*; D008297:Male; D019518:Postprandial Period; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics* / Q000502:physiology; D012007:Rectum / Q000502:physiology; D012527:Satiation / Q000502:physiology*; D012677:Sensation / Q000502:physiology*; D050486:Serotonin Plasma Membrane Transport Proteins / Q000235:genetics; D013270:Stomach / Q000033:anatomy & histology
C454420:G-protein beta3 subunit; D018341:Receptors, Adrenergic, alpha-2; C493230:SLC6A4 protein, human; D050486:Serotonin Plasma Membrane Transport Proteins; D020962:Heterotrimeric GTP-Binding Proteins